2 protocol(s) meet the specified criteria
PI: Grover, Natalie
Protocol No.TitleStatus
GO39942A Phase III, Multicenter, Randomized,Double-Blind, Placebo-Controlled Trial Comparing the Efficacy and Safety of Polatuzumab Vedotin in Combination with Rituximab and CHP (R-CHP) Versus Rituximab and CHOP (R-CHOP) in Previously Untreated Patients with Diffuse Large B-Cell LymphomaOpen
LCCC1606-ATLPhase I Study of the Administration of T lymphocytes Co-Expressing the CD30 Chimeric Antigen Receptor (CAR) and CCR4 for Relapsed/Refractory CD30+ Hodgkin Lymphoma and CD30+ Non-Hodgkin LymphomaOpen